Correlation Between Edesa Biotech and Eli Lilly

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Edesa Biotech and Eli Lilly at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edesa Biotech and Eli Lilly into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edesa Biotech and Eli Lilly and, you can compare the effects of market volatilities on Edesa Biotech and Eli Lilly and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edesa Biotech with a short position of Eli Lilly. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edesa Biotech and Eli Lilly.

Diversification Opportunities for Edesa Biotech and Eli Lilly

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between Edesa and Eli is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Edesa Biotech and Eli Lilly and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eli Lilly and Edesa Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edesa Biotech are associated (or correlated) with Eli Lilly. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eli Lilly has no effect on the direction of Edesa Biotech i.e., Edesa Biotech and Eli Lilly go up and down completely randomly.

Pair Corralation between Edesa Biotech and Eli Lilly

Given the investment horizon of 90 days Edesa Biotech is expected to generate 6.07 times more return on investment than Eli Lilly. However, Edesa Biotech is 6.07 times more volatile than Eli Lilly and. It trades about 0.07 of its potential returns per unit of risk. Eli Lilly and is currently generating about 0.14 per unit of risk. If you would invest  220.00  in Edesa Biotech on November 18, 2024 and sell it today you would earn a total of  49.00  from holding Edesa Biotech or generate 22.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Edesa Biotech  vs.  Eli Lilly and

 Performance 
       Timeline  
Edesa Biotech 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Edesa Biotech are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat abnormal basic indicators, Edesa Biotech sustained solid returns over the last few months and may actually be approaching a breakup point.
Eli Lilly 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Eli Lilly and are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady essential indicators, Eli Lilly showed solid returns over the last few months and may actually be approaching a breakup point.

Edesa Biotech and Eli Lilly Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Edesa Biotech and Eli Lilly

The main advantage of trading using opposite Edesa Biotech and Eli Lilly positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edesa Biotech position performs unexpectedly, Eli Lilly can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eli Lilly will offset losses from the drop in Eli Lilly's long position.
The idea behind Edesa Biotech and Eli Lilly and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years